CT-P17 Adalimumab Biosimilar in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Open-Label Extension of a Phase 3 Interchangeability Study.

Saved in:
Bibliographic Details
Title: CT-P17 Adalimumab Biosimilar in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Open-Label Extension of a Phase 3 Interchangeability Study.
Authors: Pariser DM; Eastern Virginia Medical School and Virginia Clinical Research, Inc., Norfolk, VA, USA., Lebwohl MG; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Jaworski J; Centrum Medyczne Reuma Park, Warsaw, Poland., Trefler J; Reuma Centrum, Warsaw, Poland., Daniluk S; ClinicMed Daniluk, Nowak Sp.k., Białystok, Poland., Dudek A; Centrum Medyczne AMED, Warsaw, Poland., Baran W; Department of Dermatology, Venereology and Allergology, Wrocław Medical University, Wrocław, Poland., Owczarek W; Royalderm, Warsaw, Poland.; Department of Dermatology, Military Institute of Medicine - National Research Institute, Warsaw, Poland., Brzewski P; Specjalistyczny Gabinet Dermatologiczny Aplikacyjno-Badawczy, Kraków, Poland.; Department of Dermatology, UAFM Kraków, Kraków, Poland., Sikora M; National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland., Krogulec M; Rheumatology Clinic, NZOZ Lecznica MAK-MED, Nadarzyn, Poland., Kim S; Celltrion, Inc., Incheon, Republic of Korea., Suh J; Celltrion, Inc., Incheon, Republic of Korea., Choi E; Celltrion, Inc., Incheon, Republic of Korea., Cha J; Celltrion, Inc., Incheon, Republic of Korea., Lee H; Celltrion, Inc., Incheon, Republic of Korea., Lee S; Celltrion, Inc., Incheon, Republic of Korea., Koo JY; UCSF Psoriasis and Skin Treatment Center, 515 Spruce Street, San Francisco, CA, 94118, USA. john.Koo2@ucsf.edu.
Source: Dermatology and therapy [Dermatol Ther (Heidelb)] 2025 May; Vol. 15 (5), pp. 1079-1092. Date of Electronic Publication: 2025 Mar 27.
Publication Type: Journal Article
Journal Info: Publisher: Springer Healthcare Communications Country of Publication: Switzerland NLM ID: 101590450 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8210 (Print) NLM ISO Abbreviation: Dermatol Ther (Heidelb) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2193-8210
DOI:10.1007/s13555-025-01383-5